A Maine-based Biotech Diagnostic Company with a focus on cell-based and cell-derived human diagnostics in the specific areas of detection and monitoring of fetomaternal hemorrhage, infection/sepsis and inflammatory myeloid mediated diseases. Based upon a foundation of recognized expertise in laboratory hematology and flow cytometry, Trillium Diagnostics was committed to improving healthcare by developing diagnostic assays that are innovative, robust, and reliable.